Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D: A: D study

HIV Medicine

Volumn 17, Issue 4, 2016, Pages 255-268

  Achhra, A C ^a   Mocroft, A ^b   Reiss, P ^c   Sabin, C ^b   Ryom, L ^d   de Wit, S ^e   Smith, C J ^b   d'Arminio Monforte, A ^f   Phillips, A ^b   Weber, R ^g   Lundgren, J ^d   Law, M G ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^f UNIVERSITY OF MILAN   (Italy)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Body mass index; Cardiovascular diseases; Diabetes; Highly active antiretroviral therapy; HIV; Inflammation; Myocardial infarction; Weight gain

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; BODY MASS; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBESITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SUDDEN CARDIAC DEATH; UNDERWEIGHT; WEIGHT GAIN; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; COMPLICATION; HIV INFECTIONS; MIDDLE AGED;

ADULT; ANTI-HIV AGENTS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 84961203026     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12294     Document Type: Article

References (17)

1. Tate T, Willig AL, Willig JH etal. HIV infection and obesity: where did all the wasting go? Antivir Ther 2012; 17: 1281-1289.
2. Taylor BS, Liang Y, Garduno LS etal. High risk of obesity and weight gain for HIV-infected uninsured minorities. J Acquir Immune Defic Syndr 2014; 65: e33-e40.
3. Keithley JK, Duloy AM, Swanson B, Zeller JM. HIV infection and obesity: a review of the evidence. J Assoc Nurses AIDS Care 2009; 20: 260-274.
4. Hasse B, Iff M, Ledergerber B etal. Obesity trends and body mass index changes after starting antiretroviral treatment: the Swiss HIV Cohort Study. Open Forum Infect Dis 2014; 1: ofu040.
5. Lakey W, Yang LY, Yancy W, Chow SC, Hicks C. Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons. AIDS Res Hum Retroviruses 2013; 29: 435-440.
6. Krishnan S, Schouten JT, Atkinson B etal. Changes in metabolic syndrome status after initiation of antiretroviral therapy. J Acquir Immune Defic Syndr 2015; 68: 73-80.
7. Herrin M, Tate JP, Freiberg MS etal., eds. Risk of incident diabetes associated with weight gain after cART initiation. 20th Conference on Retroviruses and Opportunistic Infections. Atlanta, GA 2013 [Abstract 804].
8. So-Armah KA, Chang J, Alcorn C etal. HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function. Curr HIV Res 2014; 12: 50-59.
9. Friis-Moller N, Reiss P, Sabin C etal. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356: 1723-1735.
10. World Health Organization (WHO). BMI classification. 2012. Available at http://apps.who.int/bmi/index.jsp?introPage=intro_3.html (accessed 17 April 2012).
11. Chrysant SG, Chrysant GS. New insights into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens 2013; 7: 85-94.
12. Friis-Møller N, Thiébaut R, Reiss P etal. Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study. Eur J Cardiovasc Prev Rehabil 2010; 17: 491-501.
13. Petoumenos K, Worm SW, Fontas E etal. Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. J Int AIDS Soc 2012; 15: 17426.
14. Crane HM, Heckbert SR, Drozd DR etal. Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts. Am J Epidemiol 2014; 179: 996-1005.
15. Vistisen D, Witte DR, Tabak AG etal. Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort study. PLoS Med 2014; 11: e1001602.
16. Erlandson K, Campbell T, Gupte N etal. Obesity and Inflammation in Resource-Diverse Settings of ART Initiation. Conference on Retroviruses and Opportunistic Infections (CROI). Seattle, WA 2015 [Abstract 778].
17. Drozd DR, Nance RM, Delaney JAC etal. Lower CD4 count and higher viral load are associated with increased risk of myocardial infarction. Conference on Retroviruses and Opportunistic Infections. Boston, MA 2014 [Abstract 739].